Invesaro

Stocks CVLT Financial statements

Financial statements

COMMVAULT SYSTEMS INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data COMMVAULT SYSTEMS INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue6456997116717237707858399961,184
Cost of revenue85.298.2117117109114135152179223
Gross profit560601594554614656649688817961
Research and development79.69192.6110133154142132146162
Selling and marketing384411370336332342341355434520
General and administrative88.990.710192.192.2103104114138163
Operating expenses561602589571636614665612743887
Operating income-1.24-0.954.91-17.5-22.341.6-15.975.473.774
Interest expense0.961.160000.110.470.420.423.8
Interest income1.162.235.524.961.030.661.35.426.6521.8
Other non-operating income001.3-0.313.251.080.12
Pre-tax income-1.99-3.510.4-12.5-21.243.4-15.483.681.192.1
Income tax-1.4958.46.87-6.99.729.7920.4-85.34.9521.5
Net income-0.51-61.93.56-5.65-3133.6-35.816976.170.7
EBITDA8.9910.817-0.44-6.3952.5-5.5681.882.884.3
EPS, basic-0.01-1.370.08-0.12-0.660.74-0.803.851.741.61
EPS, diluted-0.01-1.370.07-0.12-0.660.71-0.803.751.681.58
Shares, basic (weighted)44.745.245.845.846.745.444.743.943.944
Shares, diluted (weighted)44.745.247.645.846.747.244.745.145.244.7

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents329331328288397268288313302900
Short-term investments12113213043.60
Receivables140162177147188194210223252330
Other current assets15.822.219.82722.222.3142146.256
Total current assets6066476555146084845515956351,287
Property, plant and equipment1321291231151131078.297.968.299.75
Lease right-of-use assets1520.814.911.810.510.134.9
Goodwill0112112128128128185209
Intangible assets0046.403.542.291.0420.719.7
Other non-current assets7.2710.211.111.712.126.321.927.446.168.4
Total assets8308198228459048167839441,1181,886
Accounts payable0.120.762.190.310.370.430.110.30.370.65
Accrued liabilities78.782.385.787.111212297.9117147166
Deferred revenue209241238233253267308362403485
Total current liabilities288324326329373394410485555658
Lease liabilities8.8115.411.38.267.166.3429.7
Other non-current liabilities4.233.312.952.241.533.933.613.567.0914.8
Total liabilities3634154314335105605966667931,879
Paid-in capital6947838889791,0701,1661,2651,3501,4741,496
Retained earnings-216-374-485-554-666-899-1,063-1,056-1,134-1,472
Other comprehensive income-12.3-5.47-11.6-13.4-10.4-11.9-16.1-15.9-15.6-16.4
Shareholders' equity4674043914123942561862783257.49
Total equity4674043914123942561862783257.49
Total liabilities and equity8308198228459048167839441,1181,886
Shares outstanding44.845.145.64646.544.544.143.544.141.3

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income-0.51-61.93.56-5.65-3133.6-35.816976.170.7
Depreciation and amortization10.211.812.117.115.91110.36.429.0710.3
Stock-based compensation73.974.180.565.984.810510694.6113123
Deferred income tax-11.553.70.16-1.78-0.090.05-0.67-110-23.57.7
Change in receivables-16.4-25.1-24.126.1-34.6-20.4-11.6-21.7-25.4-74
Change in payables-0.190.621.49-2.470.050.06-0.30.2-0.950.25
Cash from operations10084.211088.5124177170204207245
Capital expenditures-6.42-7.05-6.56-3.2-8.18-3.91-3.24-4.09-3.76-7.53
Acquisitions00-1570-16.900-65.3-25.8
Purchases of investments-96.3-142-130-43.600
Cash from investing-28-18-5.26-7435.5-24.4-5.29-5.52-70.4-5.45
Share buybacks-50-112-133-77.2-95.3-305-151-184-165-446
Cash from financing-22.4-82.1-90.7-39.4-74.7-276-136-171-148345
Exchange rate effect-8.1817.2-17-6.9716.5-6.38-9.15-2.720.1913.3
Net change in cash41.41.29-2.79-31.9101-13020.325-10.7598
Free cash flow93.677.110485.3116173167200204237
Interest paid0.680.590000.010.250.250.250.67
Income taxes paid5.416.4511.562.96-1.4915.22042.213.6

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to September 30, 2026; growth uses fiscal years. Valuation uses the share price of $168.30 on November 10, 2026.

Profitability

MetricValueHow it is calculated
Gross margin81.3%Gross profit / revenue.
Operating margin7.4%Operating income / revenue.
EBITDA margin8.1%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin9.7%Pre-tax income / revenue.
Net margin6.6%Net income / revenue.
FCF margin20.4%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin21.0%Cash from operations / revenue.
Effective tax rate31.7%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)659.7%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)4.4%Net income / average total assets.
R&D / revenue13.1%Research and development expense / revenue.
Stock-based pay / revenue10.6%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.6%Capital expenditures / revenue.
D&A / revenue0.7%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y18.9%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y14.7%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y10.3%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y17.6%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y14.0%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y9.4%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y0.3%Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y1.8%EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y-7.2%Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y-6.0%EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y18.0%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y12.8%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y14.6%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y16.5%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y12.4%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y15.4%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-97.7%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-65.7%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-54.7%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y68.7%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y34.1%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y15.8%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-1.2%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-0.0%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-0.9%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.94xCurrent assets / current liabilities.
Quick ratio1.84x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio1.40x(Cash + short-term investments) / current liabilities.
Liabilities / assets99.3%Total liabilities / total assets.
Interest coverage15.9xOperating income / interest expense.
Working capital$600.3MCurrent assets - current liabilities.
Goodwill and intangibles / assets12.1%(Goodwill + intangible assets) / total assets.
Tangible book value-$213.8MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.67xRevenue / average total assets.
Fixed asset turnover92.9xRevenue / average property, plant and equipment.
Receivables turnover4.46xRevenue / average receivables.
Days sales outstanding82 days365 x average receivables / revenue.
Days payables1 days365 x average accounts payable / cost of revenue.
FCF conversion309.3%Free cash flow / net income, when net income is positive.
Capex / operating cash flow2.7%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$1.96Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$29.65Revenue / diluted weighted shares.
FCF per share$6.06Free cash flow / diluted weighted shares.
Operating cash flow per share$6.22Cash from operations / diluted weighted shares.
Book value per share$0.31Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$5.23Tangible book value / shares outstanding.
Cash per share$21.94(Cash + short-term investments) / shares outstanding.
Buybacks / FCF163.4%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$6.98BShare price x shares outstanding.
Enterprise value$6.08BMarket cap + total debt - cash - short-term investments.
P/E84.4xMarket cap / net income. Only when net income is positive.
P/S5.57xMarket cap / revenue.
P/B556xMarket cap / shareholders' equity. Only when equity is positive.
P/FCF27.3xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF26.6xMarket cap / cash from operations, when positive.
EV/Sales4.85xEnterprise value / revenue.
EV/EBIT65.7xEnterprise value / operating income, when both are positive.
EV/EBITDA60.1xEnterprise value / EBITDA, when both are positive.
EV/FCF23.8xEnterprise value / free cash flow, when both are positive.
FCF yield3.7%Free cash flow / market cap.
Earnings yield1.2%Net income / market cap (the inverse of P/E).
Shareholder yield6.0%(Dividends paid + share buybacks) / market cap.
What was COMMVAULT SYSTEMS INC's revenue in fiscal 2026?

COMMVAULT SYSTEMS INC reported revenue of $1.18B for fiscal 2026, 18.9% higher than the year before.

Was COMMVAULT SYSTEMS INC profitable in fiscal 2026?

Yes. Net income was $70.7M, a net margin of 6%.

How much free cash flow did COMMVAULT SYSTEMS INC generate in fiscal 2026?

Cash from operations of $244.7M minus capital expenditures of $7.5M left free cash flow of $237.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to COMMVAULT SYSTEMS INC